Regression of liver fibrosis in cases of chronic liver disease type C: Quantitative evaluation by using computed image analysis

被引:22
作者
Arima, M
Terao, H
Kashima, K
Arita, T
Nasu, M
Nishizono, A
机构
[1] Oita Univ, Dept Infect Dis, Hasama, Oita 8798893, Japan
[2] Oita Univ, Dept Oncol Sci, Hasama, Oita 8798893, Japan
[3] Oita Univ, Hlth Sci Ctr, Hasama, Oita 8798893, Japan
[4] Arita Gastroenterol Hosp, Hasama, Oita 8798893, Japan
关键词
computed image analysis; fibrosis; regression; interferon; hepatitis virus C;
D O I
10.2169/internalmedicine.43.902
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Object It was reported that the liver fibrosis is reduced in patients with chronic liver disease type C after eradication of HCV. Degree of fibrosis was expressed by the classical fibrosis scoring system (F0-F4) at present. However a change of subtle reduction of fibrosis cannot be expressed in its fibrosis score and thus we measured an area of fibrosis and compared detailed change of the fibrosis area in paired liver biopsy. Methods For quantitative assessment of liver fibrosis, we measured an area of fibrosis using computed digital image analysis and pursued the rate of a fibrosis area for whole biopsied liver tissue of 25 patients with HCV infection (20 complete response patients to IFN therapy who showed viral eradication: CR and 5 non-treated ones with IFN but had conservative therapy: CT). Results In CR group, fibrosis rate was 7.2 +/- 1.5% before therapy, 2.7 +/- 0.5% after the therapy and they were significantly regressed. In CT group, fibrosis rate was 8.4 +/- 4.3% at the first biopsy, 15.9 +/- 7.7% at the second biopsy. Conclusions Regression of liver fibrosis could be confirmed in patients with virologic response to IFN even in patients with liver cirrhosis. Our quantitative evaluation provided information superior to that obtained by the classical fibrosis staging score system.
引用
收藏
页码:902 / 910
页数:9
相关论文
共 22 条
[1]
Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial [J].
Alric, L ;
Duffaut, M ;
Selves, J ;
Sandre, K ;
Mularczyck, M ;
Izopet, J ;
Desmorat, H ;
Bureau, C ;
Chaouche, N ;
Dalbergue, B ;
Vinel, JP .
JOURNAL OF HEPATOLOGY, 2001, 35 (02) :272-278
[2]
Brunetto MR, 1998, LANCET, V351, P1535
[3]
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[4]
Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment [J].
Dufour, JF ;
DeLellis, R ;
Kaplan, MM .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (12) :2573-2576
[5]
Long-term biochemical and virological response to natural interferon-alpha in patients with chronic hepatitis C [J].
Hagiwara, H ;
Hayashi, N ;
Kasahara, A ;
Oshita, M ;
Katayama, K ;
Naito, M ;
Masuzawa, M ;
Yoshihara, H ;
Shimizu, Y ;
Fusamoto, H ;
Kamada, T .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (05) :1001-1007
[6]
IMPROVEMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS-C PATIENTS TREATED WITH NATURAL INTERFERON-ALPHA [J].
HIRAMATSU, N ;
HAYASHI, N ;
KASAHARA, A ;
HAGIWARA, H ;
TAKEHARA, T ;
HARUNA, Y ;
NAITO, M ;
FUSAMOTO, H ;
KAMADA, T .
JOURNAL OF HEPATOLOGY, 1995, 22 (02) :135-142
[7]
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C [J].
Imai, Y ;
Kawata, S ;
Tamura, S ;
Yabuuchi, I ;
Noda, S ;
Inada, M ;
Maeda, Y ;
Shirai, Y ;
Fukuzaki, T ;
Kaji, I ;
Ishikawa, H ;
Matsuda, Y ;
Nishikawa, M ;
Seki, K ;
Matsuzawa, Y .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) :94-99
[8]
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C [J].
Kasahara, A ;
Hayashi, N ;
Mochizuki, K ;
Takayanagi, M ;
Yoshioka, K ;
Kakumu, S ;
Iijima, A ;
Urushihara, A ;
Kiyosawa, K ;
Okuda, M ;
Hino, K ;
Okita, K .
HEPATOLOGY, 1998, 27 (05) :1394-1402
[9]
FORMULATION AND APPLICATION OF A NUMERICAL SCORING SYSTEM FOR ASSESSING HISTOLOGICAL ACTIVITY IN ASYMPTOMATIC CHRONIC ACTIVE HEPATITIS [J].
KNODELL, RG ;
ISHAK, KG ;
BLACK, WC ;
CHEN, TS ;
CRAIG, R ;
KAPLOWITZ, N ;
KIERNAN, TW ;
WOLLMAN, J .
HEPATOLOGY, 1981, 1 (05) :431-435
[10]
10-year follow-up after interferon-α therapy for chronic hepatitis C [J].
Lau, DTY ;
Kleiner, DE ;
Ghany, MG ;
Park, Y ;
Schmid, P ;
Hoofnagle, JH .
HEPATOLOGY, 1998, 28 (04) :1121-1127